Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| ALLIANCE FIB | AFOP | 15.81% |
| A M R CP | AAMRQ | 8.48% |
| JAZZ PHARMAC | JAZZ | 7.12% |
| SANTARUS INC | SNTS | 5.87% |
| DIXIE GROUP | DXYN | 4.93% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
This Zacks #1 Rank (Strong Buy) is also trading with great valuations, in addition to strong growth rates.
Company Description
Limited Brands operates about 2,700 stores in the U.S. and another 700 international locations. Notable brands include Victoria's Secret, Bath & Body Works and La Senza.
November Sales
On Dec 2 Limited Brands reported a 10% increase in comparable store sales for November. Total sales rose to $893 million, up more than 14%. The sales momentum came on the heels of a solid quarterly report.
Q3 Better than Expected
On Nov 17 Limited Brands announced operating income of just over $149 million, which was more than double the $59 million from the same period last year. Net income increased 10-fold to $61.3 million.
Earnings per share came out to 18 cents per share which is 16 cents better than last year and 1 cent ahead of the Zacks Consensus Estimate. This was the seventh earnings surprise in the past 8 quarters.
Consensus Rising
In the same press release, the company raised its outlook, which caused analysts to do the same. The Zacks Consensus Estimate for fiscal 2011 is up 12 cents in the past 2 months, to $1.97.
Next year's forecasts rose 14 cents on average, to $2.20. After earning $1.23 last year, the annual growth rates are now expected to be 60% this year and 12% in 2012.
Valuations
While Victoria's Secret may get headlines for showcasing multi-million dollar jewel-encrusted bras, you don't have to pony up too much for the stock.
Shares are trading at roughly 14 times next year's estimates. This gives LTD a PEG near 0.9, both presenting solid value. Limited Brands has a price to sales ratio of 1.1, which is in line with similar companies.
The Chart
The sharp drop in share price in early December was when shares went ex-dividend. In the previously mentioned quarterly report, Limited Brands also announced a special $3 dividend.
Currently shares are resting one what should act as a reliable support level moving forward, making for an excellent entry point.
Bill Wilton is the Aggressive Growth Stock Strategist for Zacks.com. He is also the Editor in charge of the market-beating Zacks Small Cap Trader service
Read the full reports :
Analyst Report on LTD